These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 684884)

  • 21. Significance of specific IgA antibodies in infections due to Yersinia enterocolitica and their complications.
    Hannover Larsen J
    Contrib Microbiol Immunol; 1987; 9():136-40. PubMed ID: 3665491
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serologic diagnosis and follow-up in patients with uveitis. Antibodies to virulence antigens of Yersinia enterocolitica].
    Hild M; Böhnke M; Damms T; Heesemann J
    Fortschr Ophthalmol; 1990; 87(5):484-7. PubMed ID: 2272579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yersinia enterocolitica infection in a family].
    Anańko J; Hański W
    Przegl Epidemiol; 1977; 31(2):237-9. PubMed ID: 882695
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental intramammary infection of cows with Yersinia enterocolitica O9: cellular and immunologic responses.
    Mittal KR; Barnum DA; Tizard IR
    Am J Vet Res; 1981 Feb; 42(2):311-3. PubMed ID: 6789723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoglobulin E level in acute Yersinia infection].
    Iushchuk ND; Valishin DA; Novikova TA; Eremina OF
    Klin Med (Mosk); 1991 Apr; 69(4):71-3. PubMed ID: 1865657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of Yersinia infection in the pathogenesis of diffuse toxic goiter].
    Panova TN; Pogorelova NP; Rashevskaia EV
    Ter Arkh; 1990; 62(12):93-5. PubMed ID: 2084934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Yersinia enterocolitica antibodies in sarcoidosis].
    Seebacher C; Hillmann E; Diesterweg I; Kiesewalter J
    Dermatol Monatsschr; 1979 Jun; 165(6):448-50. PubMed ID: 499631
    [No Abstract]   [Full Text] [Related]  

  • 28. [A contribution to the etiology and pathogenesis of Reiter's disease (author's transl)].
    Seebacher C; Köstler E; Gebhardt B
    Dermatol Monatsschr; 1981 May; 167(5):287-92. PubMed ID: 6974105
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis of pseudotuberculosis].
    Trinus EK; Barchuk VF; Proskuriakova NB; Polezhaeva IV
    Vrach Delo; 1981 Jul; (7):108-9. PubMed ID: 7025449
    [No Abstract]   [Full Text] [Related]  

  • 30. Serologic response of pigs to experimental infection with Yersinia enterocolitica serotype O9 and Brucella abortus.
    Mittal KR; Tizard IR
    Am J Vet Res; 1981 Mar; 42(3):443-6. PubMed ID: 6791534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
    Kobayashi S; Ogasawara M; Maeda K; Yu DT
    J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trial of tetracycline prophylaxis in individuals with persistently raised Yersinia enterocolitica antibody titres.
    Agner E; Larsen JH; Tougaard L
    Lancet; 1981 Nov; 2(8256):1175. PubMed ID: 6118618
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to Yersinia enterocolitica in a healthy population in Tanzania.
    Mhalu FS; Myrmel H; Digranes A; Oeding P
    APMIS; 1988 Apr; 96(4):377-8. PubMed ID: 3370161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perimyocarditis caused by Yersinia enterocolitica serotype 0:3].
    Zöllner B; Sobottka I; von der Lippe G; Boyens M; Pokahr A; Grüter L; Laufs R
    Dtsch Med Wochenschr; 1992 Nov; 117(47):1794-7. PubMed ID: 1425306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolates of Yersinia enterocolitica from clinical cases in Northern Israel.
    Shmilovitz M; Kretzer B
    Isr J Med Sci; 1978 Oct; 14(10):1048-55. PubMed ID: 738869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of anti-Yersinia enterocolitica antibodies in an open population of the city of Rome].
    Sebastiani L; Annicchiarico Petruzzelli B; Guglielmi A; Maldarizzi B
    Clin Ter; 1991 Jul; 138(2):87-90. PubMed ID: 1834405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD; Asmussen JU
    Z Rheumatol; 1993; 52(4):210-4. PubMed ID: 8212919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rheumatic manifestations in the presence of antibodies to Yersinia pseudotuberculosis. Apropos of 4 cases].
    Mottier D; Pennec Y; Brousse A; Youinou P; Jouquan J; Bergeret G
    Sem Hop; 1982 Sep; 58(35):1989-92. PubMed ID: 6293082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
    Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics of persistent Yersinia antibodies of the IgA class].
    Granfors K; Ogasawara M; Stälberg TH; Toivanen O; Yu D
    Ter Arkh; 1986; 58(7):24-6. PubMed ID: 3764735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.